Clinical Trial Update: Phase I Study of APX005M in Pediatric Central Nervous System Tumors [Phase 1]

View source ↗

Summary

Phase I study of APX005M in pediatric central nervous system tumors; the trial is active but not recruiting and results have been posted. Sponsored by the Pedia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Tumor
• Diffuse Intrinsic Pontine Glioma
• Ependymoma
• Glioblastoma
• High-grade Astrocytoma
• Medulloblastoma

Drugs mentioned

• APX005M

Snippet

Sponsor: Pediatric Brain Tumor Consortium | Conditions: Glioblastoma Multiforme, High-grade Astrocytoma Not Otherwise Specified (NOS) | Phase 1 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-10-10